Table 4.
Histological findings | Group–T2 |
P value | |
---|---|---|---|
BP (n = 15) | GF (n = 11) | ||
Muc. Th. | |||
Absent/Light | 6 (40.0%) | 2 (18.2%) | 0.234. |
Moderate/Severe | 9 (60.0%) | 9 (81.8%) | |
TM. Th. | |||
Absent/Light | 13 (86.7%) | 8 (72.7%) | 0.620. |
Moderate/Severe | 2 (13.3%) | 3 (27.3%) | |
LMN | |||
Absent/Light | 0 (0%) | 7 (63.6%) | 0.001a |
Moderate/Severe | 15 (100%) | 4 (36.4%) | |
PMN | |||
Absent/Light | 1 (6.7%) | 10 (90.9%) | 0.001a |
Moderate/Severe | 14 (93.3%) | 1 (9.1%) | |
Neoangio | |||
Absent/Light | 13 (86.7%) | 3 (27.3%) | 0.004a |
Moderate/Severe | 2 (13.3%) | 8 (72.7%) | |
Fibrosis | |||
Absent/Light | 9 (60.0%) | 4 (36.4%) | 0.234. |
Moderate/Severe | 6 (40.0%) | 7 (63.6%) |
Statistically significant (p < 0.05).